Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classement en actions #20516
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Prix de l'action
$20.27
Capitalisation boursière
$128.37M
Changement (1 jour)
-1.37%
Changement (1 an)
79.91%
Pays
PL
Échange Captor Therapeutics Spolka Akcyjna (CTX)

Catégorie

Ratio P/S pour Captor Therapeutics Spolka Akcyjna (CTX)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Captor Therapeutics Spolka Akcyjna, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Captor Therapeutics Spolka Akcyjna de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH